期刊文献+

造血干细胞移植后的早期免疫重建 被引量:6

Early immune reconstitution after hematopoietic stem cell transplantation
下载PDF
导出
摘要 目的:探讨异基因造血干细胞移植(allogenic hematopoietic stem cell transplantation,allo-HSCT)和自体造血干细胞移植(autologous HSCT,auto-HSCT)患者早期免疫重建的异同。方法:收集2011年12月至2014年8月在北京大学第三医院血液科进行HSCT的恶性血液病患者31例,其中15例allo-HSCT,16例auto-HSCT;留取20名健康人外周血标本作为健康对照。采用四色流式细胞术检测两组患者移植后1年内外周血中淋巴细胞亚群的动态变化,并通过检测T细胞受体重排删除环(T cell receptor rearrangement excision circle,TREC)水平判断初始T细胞功能。结果:移植后12个月内allo-HSCT组和auto-HSCT组患者CD4+T细胞、CD8初始T细胞、效应记忆性T细胞、CD4中枢记忆性T细胞、中期活化性T细胞以及DC重建与健康对照组比较差异有统计学意义(P<0.05),但两组患者间差异无统计学意义(P>0.05),CD8+T细胞和NK细胞迅速恢复正常水平。移植后前3个月内B细胞重建在两组患者间差异无统计学意义(P>0.05),均显著低于健康对照组(P<0.01),但从第6个月起auto-HSCT组显著快于allo-HSCT组患者(P<0.05);移植后第6个月起allo-HSCT组晚期活化性T细胞表达显著高于auto-HSCT组(P<0.05),而auto-HSCT组CD4初始T细胞和CD8中枢记忆性T细胞的表达高于allo-HSCT组(P<0.05)。移植后12个月内allo-HSCT和auto-HSCT组患者外周血CD3+T细胞中TREC水平显著低于年龄相近的健康对照组(P<0.05),allo-HSCT组患者外周血CD3+T细胞中的TREC水平稍高于auto-HSCT组患者,但差异无统计学意义(P>0.05)。结论:allo-HSCT和auto-HSCT患者早期免疫重建的速度和特点很相似,移植患者免疫重建主要不是由异源性移植物所决定,可能与胸腺功能受损后T细胞分化缓慢密切相关。 Objective: To search for differences in early immune reconstitution after allogenic or autologous hematopoietic stem cell transplantation( HSCT). Methods: The peripheral blood( PB) from 31 adult patients undergoing allogenic HSCT( allo-HSCT,15 patients) or autologous HSCT( auto-HSCT,16 patients) for the treatment of hematological malignancies and from 20 related healthy controls( HC)from December 2011 to August 2014 was used to analyze the kinetic recovery of lymphocyte subsets by means of flow cytometry during 12 months after HSCT. The T cell receptor rearrangement excision circle( TREC) levels among CD3+T cells were measured in the patients and HC to evaluate the thymicdependent T cell reconstitution. Results: The allo- and auto-HSCT recipients did not differ significantly in CD4+T cells,CD8 nave T cells,effecter memory T cells( TEM),CD4 central memory T cells( TCM),mid-activated T cells and dendritic cells( DC) during the follow-up( P〈0. 05). But they both differed significantly from HC( P〈0. 05). CD8+T cells and NK cells reconstructed rapidly. There was no significant difference in the numbers of B cells between the allo-and auto-HSCT groups from M1 to M3( P〈0. 05). B cells in both the groups were lower than those in HC( P〈0. 05). The recovery of B cells in auto-HSCT group was faster than in allo-HSCT group at M6 and M12( P〈0. 05). The frequencies of CD4 nave T cells and later activated T cells in allo-HSCT group were significantly higher than in auto-HSCT group at M6 and M12( P〈0. 05). The frequencies of CD8 TCM in auto-HSCT group were significantly higher than in allo-HSCT group at M6 and M12( P〈0. 05). The TREC levels were significantly lower than in both the groups compared with the age-matched HC during the follow-up( P〈0. 05). No significant difference was observed between allo-HSCT and auto-HSCT groups( P〈0. 05).Conclusion: The differences of the nature and the speed of lymphocyte reconstitutio
出处 《北京大学学报(医学版)》 CAS CSCD 北大核心 2016年第3期515-522,共8页 Journal of Peking University:Health Sciences
关键词 造血干细胞移植 自体移植 异基因移植 淋巴细胞亚群 免疫重建 Hematopoietic stem cell transplantation Autologous transplantation Allogenic transplanta tion Lymphocyte subsets Immune reconstitution
  • 相关文献

参考文献18

  • 1Kim DH, Kim JG, Sohn SK, et al. Clinical impact of early abso- lutelymphocyte count after allogeneic stem cell transplantation [ J ]. Br J Haematol, 2004, 125(2) : 217 -224. 被引量:1
  • 2Roberts MM, To LB, Gillis D, et al. Immune reconstitution fol- lowing peripheral blood stem cell transplantation, autologous bone marrow transplantation and allogeneic bone marrow transplantation [J]. Bone Marrow Transplant, 1993, 12 (5) : 469 -475. 被引量:1
  • 3Kalwak K, Gorczynska E, Toporski J, et al. Immune reconstitu-tion after haematopoietic cell transplantation in children: immuno- phenotype analysis with regard to factors affecting the speed of re- covery [J]. BrJHaematol, 2002, 118 (1):74-89. 被引量:1
  • 4丁丽,董磊,郑晓丽,林姗姗,朱恒,王志东,闫洪敏,郭子宽,王恒湘,吴祖泽.单倍体相合造血干细胞移植后早期T细胞数量及功能初步分析[J].中国实验血液学杂志,2013,21(3):702-706. 被引量:3
  • 5赵翔宇,赵晓甦,王亚哲,常英军,吕萌,王洪涛,韩婷婷,黄晓军.异基因造血干细胞移植后T辅助细胞亚群重建研究[J].中华血液学杂志,2013,34(9):745-750. 被引量:2
  • 6Storek J, Geddes M, Khan F, et al. Reconstitution of the immune system after hematopoietic stem cell transplantation in humans [J]. Semin Immunopathol, 2008, 30 (4) : 425 -437. 被引量:1
  • 7Neven B, Leroy S, Decaluwe H, et al. Long-term outcome after hematopoietic stem cell transplantation of asingle-center cohort of 90 patients with severe combined immunodeficiency [J ]. Blood, 2009, 113 (17) : 4114 -4124. 被引量:1
  • 8Benedicte PL, Anne H, Michel A, et al. Evolution of peripheral blood T lymphocyte subsets after allogenic or autologous bematopoi- eric stem cell transplantation [ J ]. Immunobiology, 2014, 219 (8) : 611 -618. 被引量:1
  • 9Savani BN, Rezvani K, Mielke S, et al. Factors associated with early molecular remission after T cell-depleted allogeneic stem cell transplantation for chronic myeogenous leukemia [ J ]. Blood, 2006, 107(4) : 1688 - 1695. 被引量:1
  • 10Rueff J, Medinger M, Helm D, et al. Lymphocyte subset recovery and outcome after autologous hematopoietic stem cell transplanta- tion for plasma cell mye|oma [ J ]. Bio Blood Marrow Transplant, 2014, 20(6) : 881 -903. 被引量:1

二级参考文献32

  • 1韩伟,陆道培,黄晓军,刘开彦,陈欢,许兰平,刘代红,江倩,陈育红,路瑾,王静波,吴彤,董陆佳,任汉云.HLA配型不合造血干细胞移植GIAC方案100例临床分析[J].中华血液学杂志,2004,25(8):453-457. 被引量:68
  • 2陈瑶,陆道培,刘开彦,董陆佳,任汉云,黄晓军,陈欢,刘代红,江倩,陈育红,许兰平,张耀臣,路瑾,高志勇.异基因造血干细胞移植后急性移植物抗宿主病151例危险因素分析[J].中华血液学杂志,2005,26(2):74-77. 被引量:29
  • 3Powles RL, Morgenstern GR, Kay HE, et al. Mismatched family do- nors for bone-marrow transplantation as treatment for acute leukaemi- a. Lancet, 1983 ;1 (8325) :612 -615. 被引量:1
  • 4Guinan EC, Boussiotis VA, Neuberg D, et al. Transplantation of an- ergic histoincompatible bone marrow allografts. N Engl J Med, 1999;340(22):1704- 1714. 被引量:1
  • 5Goldman FD, Rumelhart SL, DeAlacron P, et al. Poor outcome in children with refractory/relapsed leukemia undergoing bone marrow transplantation with mismatched family member donors. Bone Marrow Transplant, 2000 ; 25 (9) :943 - 948. 被引量:1
  • 6Ji SQ, Chen HR, Wang HX, et al. G-CSF-primed haploidentical marrow transplantation without ex vivo T cell depletion: an excellent alternative for high-risk leukemia. Bone Marrow Transplant, 2002; 30(12) :861 - 866. 被引量:1
  • 7Lu DP, Dang L, Wu T, et al. Conditioning including antithymocyte globulin followed by unmanipulated HLA-mismatched/haploidentical blood and marrow transplantation can achieve comparable outcomes with HLA-identical sibling transplantation. Blood, 2006 ; 107 ( 8 ) : 3065 - 3073. 被引量:1
  • 8Huang XJ. Current status of haploidentical stem cell transplantation for leukemia. J Hematol Oncol, 2008 ; 1 ( 1 ) :27 - 36. 被引量:1
  • 9Wang HX, Yan HM, Duan LN, et al. Haploidentical hematopoietic stem cell transplantation in children hematologic malignancies with G-CSF mobilized marrow grafts without T cell depletion: a single center report of 45 cases. Pediatr Hematol Oncol, 2009 ; 26 ( 3 ) : 119 - 128. 被引量:1
  • 10Thomson BG, Robertson KA, Gowan D, et al. Analysis of engraft-ment, graft-versus-host disease, and immune recovery following unre- lated donor cord blood transplantation. Blood, 2000 ; 96 ( 8 ) : 2703 -2711. 被引量:1

共引文献3

同被引文献38

引证文献6

二级引证文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部